Effects of the Antidiabetic Drugs Evogliptin and Sitagliptin on the Immune Function of CD26/DPP4 in Th1 Cells

This study aimed to investigate whether the antidiabetic drugs dipeptidyl peptidase 4 (DPP4) inhibitors such as evogliptin and sitagliptin affect the membrane DPP4 (mDPP4) enzymatic activity and immune function of T helper1 (Th1) cells in terms of cytokine expression and cell profiles. The mDPP4 enz...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Hyunyee, Sung, Ji Hyun, Song, Moon Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921863/
https://www.ncbi.nlm.nih.gov/pubmed/33148870
http://dx.doi.org/10.4062/biomolther.2020.150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921863/
https://www.ncbi.nlm.nih.gov/pubmed/33148870
http://dx.doi.org/10.4062/biomolther.2020.150

Ejemplares similares